Want to join the conversation?
$CORE said 2016 net sales are now expected to be $14.0-14.5Bil, up from $13.4-13.8Bil. Adjusted EBITDA for 2016 is now expected to be $157-164MM, up from $153-160MM. Diluted EPS for the full year is expected to be $2.31-2.46, up from $2.26-2.41. Diluted per-share estimates, excluding LIFO expense, are expected to be $2.65-2.80, up from $2.60-2.75.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.